section_path: Treatment and management/Medication/Cannabinoid addiction
section_name: Cannabinoid addiction
paragraph_text: Cannabinoid addiction
  
  The development of CB1 receptor agonists that have reduced interaction with β-arrestin 2 signaling might be therapeutically useful. As of 2019, there has been some evidence of effective pharmacological interventions for cannabinoid addiction, but none have been approved.